iota Biosciences
Private Company
Total funding raised: $50M
Overview
iota Biosciences is a private, clinical-stage bioelectronics company developing a novel platform of ultrasound-powered, ultra-miniature implantable devices. Its core technology, originating from UC Berkeley research, enables wireless, battery-free neural interfaces for therapeutic neuromodulation and sensing. The company is advancing programs in neurological and urological therapies, backed by the strategic partnership and resources of its parent company, Astellas Pharma.
Technology Platform
Ultrasound-powered, millimeter-scale, wireless, battery-free implantable bioelectronic devices for neural sensing and stimulation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
iota competes in the neuromodulation and bioelectronic medicine space against large medtech players (e.g., Medtronic, Boston Scientific, Abbott) with traditional implanted systems, and a growing number of startups developing miniaturized/wireless solutions (e.g., SetPoint Medical, NeuroOne). Its ultrasound-powered, battery-free approach is a key differentiator.